Upstream Processing

GettyImages/alexskopje

Compugen licenses Selexis cell line tech

By Dan Stanton

Compugen has selected Selexis’ SUREtechnology cell expression platform to generate high-performance research cell banks (RCBs) and support its antibody pipeline.

Follow us

Products

View more

Webinars